Hot Logistics Stocks To Invest In 2014

The offshore penetration rates for Cognizant Technology Solutions Corp (NASDAQ: CTSH) remain low for all Horizons as the company continues to see opportunity even in financial services with under-penetrated regional banks that have provided upside for the vertical throughout FY13.

Cognizant provides information technology, consulting, and business process outsourcing services. Headquartered in Teaneck, New Jersey, Cognizant has over 50 delivery centers worldwide and has approximately 164,300 employees.

Cognizant operates under three segments ��Financial, Healthcare and Manufacturing/Retail/Logistics. The company categorizes its service offerings in three groups: Horizon 1 (application development and maintenance), Horizon 2 (BPO, IT Infrastructure Services & business consulting) and Horizon 3 ("SMAC" - Social, Mobile, Analytics and Cloud).

5 Best Cheap Stocks To Watch Right Now: Investors Title Company(ITIC)

Investors Title Company, through its subsidiaries, provides title insurance to residential, institutional, commercial, and industrial properties. It underwrites land title insurance for owners and mortgagees as a primary insurer; and offers the reinsurance of title insurance risks to other title insurance companies. The company also provides tax-deferred real property exchange services, as well as serves as an exchange accommodation titleholder and holds property for exchangers in reverse exchange transactions; offers investment management and trust services to individuals, companies, banks, and trusts; and provides consulting services to title insurance agencies. Investors Title Company serves various customers in the residential and commercial market sectors of the real estate industry. It issues title insurance policies primarily through approved attorneys from underwriting offices, as well as through independent issuing agents in 24 states and the District of Columbia, the United States. The company was founded in 1972 and is headquartered in Chapel Hill, North Carolina.

Advisors' Opinion:

• [By CRWE]

  Investors Title Company (NASDAQ:ITIC), reported its results for the second quarter ended June 30, 2012. Net income increased 110.0% to $3,349,488, or $1.57 per diluted share, compared with $1,594,805, or $0.74 per diluted share, for the prior year quarter.

Hot Logistics Stocks To Invest In 2014: Grupo Simec S.A. de C.V. (SIM)

Grupo Simec, S.A.B. de C.V., together with its subsidiaries, engages in the manufacture, processing, and distribution of special bar quality (SBQ) steel and structural products primarily in the United States, Mexico, and Canada. Its steel products include I-beams; channels; structural and commercial angles; hot rolled bars, such as round, square, and hexagonal rods; flat bars; rebars; cold finished bars; wire rods; semi-finished tube rounds; and other semi-finished trade products. The company�s SBQ products are used in various engineered end-user applications, including axles, hubs, and crankshafts for automobiles and light trucks, machine tools, and off-highway equipment; and structural steel products are used in the non-residential construction market and other construction applications, as well as automotive industries. It also operates in Latin America, Europe, and Asia. The company was founded in 1969 and is headquartered in Guadalajara, Mexico. Grupo Simec, S.A.B. d e C.V. is a subsidiary of Industrias CH, S.A.B. de C.V.

Advisors' Opinion:

• [By Daniel Cross]

  Grupo Simec (NYSE: SIM) is a relatively obscure company with a $1.7 billion market cap that makes special bar-quality steel for North American markets. The company has significant downside protection in the form of its cash and cash equivalents of $623 million and total liabilities of just $665 million. Simec is also aggressively buying back stock. On a technical level, the relative strength index is hovering around 31, signaling that the stock may be oversold.

Hot Logistics Stocks To Invest In 2014: TomTom NV (TMOAF.PK)

TomTom NV is the Netherlands-based supplier of location and navigation products and services. The Company�� offer includes maps, speed cameras, portable navigation devices (PND), fleet management services (FMS), and smart phone applications. It consists of four customer-facing segments: Consumer, Automotive, Business Solutions and Licensing. The Consumer segment is engaged in the sale of PNDs, speed cameras, maps and other related navigation services to end customers. Automotive sells in-dash navigation solutions, speed cameras, grade maps and services to companies in automotive segment, as well as PNDs for fitness products. The Business solutions segment provides fleet management services and solutions, such as fleet trackers, to fleet owners. Licensing sells digital maps, mobile applications and other content to customers within multiple market segments. The Company operates in over 35 countries worldwide. In July 2013, it acquired Coordina (Gestion Electronica Logistica, S.L.). Advisors' Opinion:

• [By Genesis Housing]

  Nokia's HERE division is worth E1bn assuming a similar market cap as TomTom (TMOAF.PK) but offers significant upside as maps become the next platform for e-commerce. Assuming Nokia's net cash position declines to E2bn at Q3 from E4.1bn in Q2 (given the E1.7bn NSN deal as well as incremental cash burn due to supporting product launches), the combined value of Nokia's Net Cash, HERE division and NSN division is in line with the current market cap of Nokia.

Hot Logistics Stocks To Invest In 2014: Gran Tierra Energy Inc (GTE)

Gran Tierra Energy Inc. (Gran Tierra) is an independent international energy company engaged in oil and gas acquisition, exploration, development and production. Gran Tierra owns oil and gas properties in Colombia, Argentina, Peru and Brazil. During the year ended December 31, 2011, the Company focused on development of producing fields and generation of exploration prospects in Colombia, including the acquisition of three blocks in the Petrolifera acquisition and the acquisition of a working interest in the Llanos 22 Block. It delivers its oil to Ecopetrol S.A. (Ecopetrol) through its transportation facilities, which include pipelines, gathering systems and trucking. On March 18, 2011, the Company acquired of all the issued and outstanding common shares and warrants of Petrolifera Petroleum Limited (Petrolifera). Advisors' Opinion:

• [By Eric Lam]

  Bankers Petroleum Ltd. and Legacy Oil & Gas Inc. climbed at least 4.1 percent as the price of crude advanced. Gran Tierra Energy Inc. (GTE) added 4.7 percent after boosting its 2013 production forecasts. Bank of Montreal added 0.6 percent after naming a chief operating officer. Argonaut Gold Inc. dropped 6.5 percent to pace losses among metals miners. SNC-Lavalin Group Inc. sank 4.5 percent after cutting its earnings forecast for the year.

• [By Richard Moroney]

  Based in Canada, Gran Tierra Energy (GTE) explores for oil and gas in Colombia, Argentina, Peru, and Brazil. In August, management raised its full-year production guidance, with the midpoint implying 27% growth.

• [By Caiman Valores]

  The volume of Whitecap's proved and probable reserves also compares favorably to many of the company's peers, as shown by the chart below being higher than similarly sized Canadian peers Gran Tierra Energy (GTE) and Petrominerales (PMGLF.PK).

Hot Logistics Stocks To Invest In 2014: Flotek Industries Inc (FTK)

Flotek Industries, Inc. (Flotek), incorporated on May 17, 1985, is a diversified global supplier of drilling and production related products and services. Its core focus is oilfield specialty chemicals and logistics, down-hole drilling tools and down-hole production tools used in the energy and mining industries. Flotek operates in three segments: Chemicals and Logistics, Drilling Products and Artificial Lift. The Company operates using third party agents in Canada, Mexico, Central America, South America, the Middle East, and Asia. In May 2013, Flotek Industries Inc through its wholly owned subsidiary acquired the entire share capital of Florida Chemical Co Inc.

Chemicals and Logistics

The chemical business provides oil and natural gas field specialty chemicals for use in drilling, cementing, stimulation and production activities. The Company�� specialty chemicals are manufactured to withstand a range of down-hole pressures, temperatures and other well-specific conditions. Flotek operates two laboratories, a technical services laboratory and a research and development laboratory, which focus on design, development and testing of new chemical formulations and enhancement of existing products, often in cooperation with the customers. Its micro-emulsions are stable mixtures of oil, water and surface active agents, forming complex nano-fluids, in which the molecules are organized into nanostructures. The micro-emulsions are composed of renewable plant derived cleaning ingredients and oils and are biodegradable. Flotek�� logistics business designs, project manages and operates automated bulk material handling and loading facilities. These bulk facilities handle oilfield products, including sand and other materials for well-fracturing operations, dry cement and additives for oil and gas well cementing, and supply materials used in oilfield operations.

Drilling Products

Flotek is a provider of down-hole drilling tools used in the oilfield, min! ing, water-well and industrial drilling activities. It manufactures, sells, rents and inspects specialized equipment for use in drilling, completion, and production and workover activities. The rental tools include stabilizers, drill collars, reamers, wipers, jars, shock subs, wireless survey, and measurement while drilling (MWD) tools and mud-motors. Equipment sold primarily includes mining equipment, centralizers and drill bits. Flotek focuses its product marketing primarily in the Southeast, Northeast, Mid-Continent and Rocky Mountain regions of the United States, with international sales conducted through third party agents.

Artificial Lift

Flotek provides pumping system components, electric submersible pumps (ESPs), gas separators, production valves and services. The products address the needs of coal bed methane and traditional oil and gas production to move gas, oil and other fluids from the producing horizon to the surface. The Artificial Lift products employ technologies to improved performance. The Petrovalve product optimizes pumping efficiency in horizontal completions, heavy oil and wells with high liquid to gas ratios. Artificial Lift products are manufactured in China, assembled domestically and distributed globally.

Advisors' Opinion:

• [By David Smith]

  Flotek Industries (NYSE: FTK  )
  I've mentioned Flotek Industries to Fools in the past. The relatively small ($940 million capitalization and growing) company provides a range of products and assistance for oil and gas operations, from well construction to production. It's also the only services company -- and one of but a handful of companies in any sector -- that's been accorded a perfect consensus of one (strong buy) by the analysts.

• [By David Smith]

  Flotek Industries (NYSE: FTK  )
  The smallest member of the trio, with a market cap of about $815 million, Flotek operates on the services side of the energy sector. As I've previously pointed out to Fools, it also constitutes a rare instance wherein the analysts who monitor the company all accord it strong buy ratings. But with Flotek's share price having risen by more than 40% year to date, it is difficult to contest that unanimous confidence.

Hot Logistics Stocks To Invest In 2014: Interleukin Genetics Inc (ILIU.PK)

Interleukin Genetics, Inc., incorporated on March 28, 2000, is a personalized health company, which develops genetic tests to provide information to manage health and specific health risks. The Company�� business focuses on personalized health, by providing genetic tests with clinical value. Its tests are made available through marketing partners or directly to end users. The Company's primary business focus and strategy is to continue the Company's commercialization efforts with its PST genetic test. In addition, the Company plans to continue to develop and sells tests for its own business needs under the Inherent Health brand.

The Company's genetic tests that are being commercialized includes PST is a genetic test, which analyzes genetic variations associated with inflammation and identifies individuals who are at increased risk for more severe periodontal disease; Weight Management Genetic Test determines whether a low fat, low carbohydrate or balanced diet may normal or vigorous exercise, which is needed to lose existing body fat; Bone Health Genetic Test is designed to identify whether an individual is more likely to be susceptible to spine fractures and low bone mineral density associated with osteoporosis; Heart Health Genetic Test is designed to identify genetic predisposition to excess inflammation, which is a risk factor for heart attack, and Wellness Select Genetic Test allows buyers to purchase any combination of Inherent Health genetic tests at a discounted price. The Company is also focusing its genetic test development efforts on the development of an Osteoarthritis, or OA, genetic test to identify individuals at increased risk for severe OA.

Genetic Test for Risk of Periodontal Disease

PST is a genetic test that analyzes genetic variations associated with inflammation and identifies individuals who are at increased risk for more severe periodontal disease. The PST genetic test identifies specific polymorphisms (genetic variations) in genes that! regulate the production of interleukin cytokines.Interleukin-1 (IL-1) is well-established as one of the critical regulators of periodontal disease, and studies in non-human primates have shown that drugs specifically blocking IL-1 alone or IL-1 plus TNFa reduces tissue destruction even when the bacterial challenge is not reduced.

Inherent Health Brand of Genetic Tests

The Company's Weight Management Genetic Test helps take the guesswork out of finding an effective diet and exercise solution by revealing actionable steps to achieve weight goals based on genetics. The test provides new information beyond traditional assessments, so that nutritional intake and fitness routines can be tailored for improved, sustainable results. This test identifies five SNPs in four human genes: fatty acid binding protein 2 (FABP2); adrenergic receptor beta 2 (ADRB2 two variations); adrenergic receptor beta 3 (ADRB3); and peroxisome proliferator-activated receptor gamma (PPAR- ). These markers are involved in certain physiological pathways relating to body weight. Certain patterns of markers are associated with differential response to certain diet and exercise regimens.

The Company has conducted a number of studies that demonstrate a gene-diet interaction based on the multi-locus patterns . In the original study, 311 overweight/obese (body mass index, 27-40 kg/m2), nondiabetic, premenopausal, generally healthy women were randomly assigned for 12 months to either the Atkins-like ( low carbohydrate), Zone-like (low carbohydrate), LEARN-like (balanced), or Ornish-like (low fat) diets for the primary purpose of losing weight. The data collected in that study included dietary intake assessment (three unannounced 24-hour recalls for each time point administered by a dietitian and analyzed using NDS-R, University of Minnesota), anthropometric measures including weight, and related physiological variables, all collected at baseline, two, six, and 12 months.

Bone Health Genetic T! est

The Company's Bone Health Genetic Test is designed to identify whether an individual is more likely to be susceptible to spine fractures and low bone mineral density associated with osteoporosis. Although it typically starts later in life, early intervention can help prevent osteoporosis. Preventive measures can reduce the risk for bone loss and fractures, which in the case of vertebral fractures leads to a hunched over appearance. The test identifies a SNP in each of three genes involved in processes that affect bone; estrogen receptor alpha (ER1 Xba1), vitamin D receptor (VDR), and interleukin-1 (IL-1). Certain patterns of variations are associated with increased risk of spine fracture and/or low bone mineral density. The test can be used as an aid to making diet, exercise, and other lifestyle choices to maintain and improve bone health.

Nutritional Needs Genetics Test

The Company's Nutritional Needs Genetics Test is designed to identify DNA variations in genes crucial to B-vitamin metabolism and the ability to manage oxidative stress. Individuals with certain variations in these genes may be at increased risk for ineffective utilization of B-vitamins and potential for cell damage caused by oxidative stress, both of which can in some cases lead to increased risk for certain diseases. The test identifies the presence or absence of human genotypic markers methylenetetrahydrofolate reductase (MTHFR) and transcobalamin II (TCN2) involved in vitamin B metabolism and markers superoxide dismutase 2 (SOD2), glutathione S-transferase 1 deletions (GSTM1), paraoxonase 1 (PON1), X-ray repair cross complementing group 1 (XRCC1) in response to oxidative stress. Certain variations are associated with less efficient B-vitamin metabolism or reduced activity of endogenous anti-oxidant systems. The test may be used to aid individuals in deciding whether to supplement their diet with B vitamins and/or antioxidants.

Genetic Test Pipeline

The Company is focusing! its gene! tic test development efforts on programs, including Osteoarthritis Genetic Test. OA is the common adult joint disease, increasing in frequency and severity in all aging populations. The estimated U.S. prevalence is 20-40 million patients or five times that of rheumatoid arthritis. The Company's OA program plans to investigate whether interleukin gene variations together with several other inflammatory gene variations is associated with the occurrence of multi-joint OA for the development of a genetic risk assessment test.

Advisors' Opinion:

• [By Brian Marckx]

  Interleukin Genetics, Inc. (ILIU.PK) develops genetic tests focused on personal health. Through applied genetics research and scientific collaborations, the company has made significant progress in understanding how genetic make-up can affect an individual's predisposition and risk of suffering from certain diseases. Interleukin's research has specifically focused on a form of genetic variation called single nucleotide polymorphisms (SNP) and how it can have an impact on a person's health. The company has applied this knowledge in the development of genetic tests focused on areas such as weight management, cardiovascular health and periodontal disease. Interleukin sells its Inherent Health line of tests, which launched in 2009, to the consumer market and maintains a CLIA-certified lab at its headquarters in Waltham, Massachusetts, where consumers send test samples for processing.